Four-year follow-up of endoscopic gastroplication for the treatment of gastroesophageal reflux disease

Figure 1 Flow diagram of follow-up. ¹Between 12 and 48 mo, 9 patients had antireflux treatment: 8 patients underwent antireflux surgery and 1 an alternative endoscopic treatment.

Figure 2 Medication use at 3 mo after endocinch and at the end of follow-up. Presented as percentage of the baseline dose. Interquartile range (IQR) , range and median are shown; Median values were 31% and 97% for 3 mo and end of follow-up, respectively (^bP < 0.001, ^dP < 0.001, both compared with baseline).

Figure 3 Kaplan-Meier survival curves. Analysis of proportion of patients responding to Endocinch during follow-up; All treatment failures (i.e., > 50% of baseline acid-suppressive dose or other antireflux treatment) were included.